Research Topics
Species | Peter A ArgentaSummaryAffiliation: University of Minnesota Country: USA Publications
| Collaborators
|
Detail Information
Publications
Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot studyPeter A Argenta
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 129:81-5. 2013..We aimed to evaluate the feasibility and tolerability of hyperthermic intraperitoneal carboplatin (HIPEC-carboplatin) following secondary cytoreduction for recurrent, platinum-sensitive ovarian cancer...
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patientsJohn D Andersen
Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE Minneapolis, MN, USA
J Ovarian Res 3:21. 2010..We previously demonstrated the upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) in the sera of ovarian cancer patients compared to healthy women using quantitative mass spectrometry...
Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role?Peter A Argenta
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, USA
J Reprod Med 53:3-7. 2008..To determine if pelvic examination affected management in patients undergoing first-line chemotherapy for ovarian cancer and to determine a threshold of change in tumor size reliably detectable by pelvic examination...- Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancerPeter A Argenta
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Gynecol Oncol 97:659-61. 2005..This option is particularly appealing for younger or nulliparous patients, in whom fertility may be highly desired... - A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancerPeter A Argenta
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis MN 55455, USA
Gynecol Oncol 113:205-9. 2009..Grade 1 toxicity included headache (1 patient) and bromidrosis (2 patients). Conclusions. Fulvestrant is well-tolerated and efficacious. Objective response rates are low, but disease stabilization was common... - Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: a case report, review of the literature, and an argument for consolidationPeter A Argenta
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, MN, USA
Gynecol Oncol 107:130-5. 2007..quot;Proximal" type epithelioid sarcoma (PES) and malignant rhabdoid tumor (MRT) describe a rare subset of vulvar malignancies which share histologic features and an aggressive clinical course... - S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survivalMelissa S DeRycke
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA
Am J Clin Pathol 132:846-56. 2009..In the endometrioid subtype of ovarian and endometrial cancers, relapse-free survival was decreased for patients with S100A1+ tumors. These data suggest that S100A1 is a marker for poor prognosis of endometrioid subtypes of cancer... - A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancerMelissa A Geller
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 121:112-7. 2011..To determine feasibility and efficacy of administering docetaxel and carboplatin chemotherapy followed by pelvic radiotherapy and then consolidation chemotherapy in patients with advanced or recurrent endometrial cancer... - Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancersMelissa A Geller
Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, MMC 395 420 Delaware St SE, Minneapolis, MN, 55455, USA
Cancer Immunol Immunother 59:1877-84. 2010..Secondary objectives included assessment of safety and immune system activation... - Estrone sulfatase activity in patients with advanced ovarian cancerJustin C Chura
Department of Obstetrics, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA
Gynecol Oncol 112:205-9. 2009..We sought to identify whether the sulfatase pathway was present in ovarian cancer specimens and then to determine whether a clinical correlation existed between sulfatase activity and survival... - A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomyPatricia L Judson
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
Gynecol Oncol 95:226-30. 2004.... - Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trialLevi S Downs
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA
Gynecol Oncol 120:265-9. 2011.... - The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancerRajul Kothari
Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 119:491-5. 2010.... - On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterusKathryn E Dusenbery
Department of Therapeutic Radiology Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
Am J Clin Oncol 28:295-300. 2005.... - A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinomaLevi S Downs
Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
Cancer 112:331-9. 2008..Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide... - A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinomaMelissa A Geller
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 118:19-23. 2010..We sought to evaluate the outcomes and feasibility associated with delivering sequential chemotherapy and radiation in advanced stage endometrial cancer... - Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature reviewJustin C Chura
Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Division of Gynecologic Oncology, 420 Delaware Street SE, MMC 395, Minneapolis, MN 55455, USA
Gynecol Oncol 107:79-85. 2007..Consequently, the optimal management strategy is not defined. We reviewed our institution's experience with brain metastasis from endometrial cancer along with the extant medical literature to develop management recommendations... - Solitary fibrous tumors arising from the female pelvisThanasak Sueblinvong
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology University of Minnesota, Minneapolis, Minnesota, USA
Obstet Gynecol 118:470-4. 2011..Solitary fibrous tumor arising from the female genital tract is extremely rare and the management of this condition is controversial... - Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experienceJoseph J Ivy
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 114:420-3. 2009..We sought to evaluate the complication rate of two separate intraperitoneal chemotherapy port delivery systems used within a single practice... - Learning about ovarian cancer at the time of diagnosis: video versus usual careMelissa A Geller
Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA
Gynecol Oncol 119:370-5. 2010..We evaluated the effects of an educational video on patients' distress, cancer knowledge, coping skills and attitudes regarding learning about cancer at the time of ovarian cancer diagnosis... - A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerMelissa A Geller
Obstetrics and Gynecology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Cytotherapy 13:98-107. 2011..We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer... - Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignanciesMelissa A Geller
Division of Gynecologic Oncology, University of Minnesota, Department of Obstetrics, Gynecology and Women s Health, Minneapolis, MN 55455, USA
Eur J Obstet Gynecol Reprod Biol 143:93-7. 2009..To evaluate the feasibility and morbidity of using saline filled tissue expanders (TE) to displace the small bowel during radiation therapy in patients with gynecologic malignancies... - Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancerPatricia L Judson
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, 420 Delaware Street Southeast, MMC 395, Minneapolis, MN 55455, USA
Gynecol Oncol 91:389-94. 2003.... - A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancerLevi S Downs
Department of Obstetrics, Gynecology and Women s Health, Division of Gynecologic Oncology, University of Minnesota Medical School, Minneapolis, MN 55455, USA
Gynecol Oncol 95:347-51. 2004..To determine toxicity and establish a maximum tolerated dose of outpatient therapy with ifosfamide, paclitaxel, and carboplatin in women with advanced and recurrent cervical cancer... - Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarkerMelissa S DeRycke
Dept of Laboratory Medicine and Pathology, MMC 609, 420 Delaware St, SE, Minneapolis, MN 55455, USA
Am J Clin Pathol 134:835-45. 2010.... - A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancerPatricia L Judson
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, MN 55455, USA
Gynecol Oncol 93:667-70. 2004..To identify the nature and degree of toxicity of Temozolomide in this group of patients... - A multi-institutional review of outcomes of endometrial stromal sarcomaCharles A Leath
Department of Obstetrics, Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
Gynecol Oncol 105:630-4. 2007..To compare the clinical behavior and outcomes of low- and high-grade endometrial stromal sarcomas (LGESS and HGESS), respectively... - Hysteroscopy and cytology in endometrial cancerWilliam H Bradley
Department of Obstetrics, Gynecology and Women's Health, Division of Gynecology Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA
Obstet Gynecol 104:1030-3. 2004..Further, there appears to be an association between hysteroscopy and upstaging patients due to cytology alone. LEVEL OF EVIDENCE: II-2... - Vulvar cancer in young women: demographic features and outcome evaluationGrainger S Lanneau
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Am J Obstet Gynecol 200:645.e1-5. 2009..The objective of the study was to identify prognostic and environmental factors associated with vulvar carcinoma in young women... - Steroid-converting enzymes in human ovarian carcinomasJustin C Chura
Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, Minneapolis, MN, USA
Mol Cell Endocrinol 301:51-8. 2009..Evaluation of 17beta-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy... - Stage II squamous cell carcinoma of the vagina in a patient with Bloom syndrome: a case reportChristine S Goudge
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women s Health, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN 55455, USA
J Reprod Med 52:557-9. 2007..Bloom syndrome (BS) is a rare autosomal recessive disorder characterized by dwarfism and a predisposition to cancer. Squamous cell vaginal cancer is also quite rare and has not before been reported in association with BS... - Differential gene expression identifies subgroups of ovarian carcinomaAmy P N Skubitz
Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minn 55455, USA
Transl Res 148:223-48. 2006..In addition, the genes identified as over-expressed in each set of serous ovarian carcinoma compared with normal tissues may represent potential biomarkers and/or targets for therapy... - Results of introducing a rapid recovery program for total abdominal hysterectomyElizabeth Dickson
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women s Health, University of Minnesota, Minneapolis, Minn, USA
Gynecol Obstet Invest 73:21-5. 2012..To review the impact of implementing a rapid recovery protocol (RRP) for patients undergoing abdominal hysterectomy... - Vacuum-assisted closure in the treatment of complex gynecologic wound failuresPeter A Argenta
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mount Sinai Medical Center, New York, New York 10029, USA
Obstet Gynecol 99:497-501. 2002..They are costly and time consuming to treat, and may evolve into chronic, debilitating conditions. Vacuum-assisted closure is a novel wound healing technique applying subatmospheric pressure to wounds to expedite healing... - Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 21:4222-7. 2003....